Abstract
Chronic obstructive pulmonary disease (COPD) affects over 10% of the adult population worldwide and is currently projected to become the third leading cause of death by year 2030 [1]. We believe, COPD should be viewed as a multisystem disorder with clearly identified extra-pulmonary manifestations including weight loss, myopathy, cardiovascular diseases, diabetes, malignancies, bone mineral disease and psychological disorders. Most of these comorbidities are also important not only to understand the burden of this progressive disease, but also to devise effective therapeutic strategies [2]. This article reviews the current understanding of the systemic manifestations of COPD, which includes everything except airflow obstruction, emphysema and chronic bronchitis. For colleagues interested in reviewing the main component of COPD therapy, we urge to review an excellent article published in American Journal of Respiratory Critical Care Medicine volume 187, page 337- 365, Feb 15, 2013.
Keywords: Airflow obstruction, chronic bronchitis, COPD, pneumonia, pulmonary disease, pulmonary venous thrombo-embolism.
Current Respiratory Medicine Reviews
Title:COPD Evaluation: Beyond the Airway Obstruction, a Follow Up
Volume: 9 Issue: 2
Author(s): Asif Najmuddin, Naga Sirikonda and Harakh V. Dedhia
Affiliation:
Keywords: Airflow obstruction, chronic bronchitis, COPD, pneumonia, pulmonary disease, pulmonary venous thrombo-embolism.
Abstract: Chronic obstructive pulmonary disease (COPD) affects over 10% of the adult population worldwide and is currently projected to become the third leading cause of death by year 2030 [1]. We believe, COPD should be viewed as a multisystem disorder with clearly identified extra-pulmonary manifestations including weight loss, myopathy, cardiovascular diseases, diabetes, malignancies, bone mineral disease and psychological disorders. Most of these comorbidities are also important not only to understand the burden of this progressive disease, but also to devise effective therapeutic strategies [2]. This article reviews the current understanding of the systemic manifestations of COPD, which includes everything except airflow obstruction, emphysema and chronic bronchitis. For colleagues interested in reviewing the main component of COPD therapy, we urge to review an excellent article published in American Journal of Respiratory Critical Care Medicine volume 187, page 337- 365, Feb 15, 2013.
Export Options
About this article
Cite this article as:
Najmuddin Asif, Sirikonda Naga and Dedhia V. Harakh, COPD Evaluation: Beyond the Airway Obstruction, a Follow Up, Current Respiratory Medicine Reviews 2013; 9 (2) . https://dx.doi.org/10.2174/1573398X113099990002
DOI https://dx.doi.org/10.2174/1573398X113099990002 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Depression and its Relation with Uncontrolled Hypertension and Increased Cardiovascular Risk
Current Hypertension Reviews Renoprotective Potency of Heme Oxygenase-1 Induction in Rat Renal Ischemia-Reperfusion
Inflammation & Allergy - Drug Targets (Discontinued) Atrial Tachycardias Arising from the Atrial Appendages and Aortic Sinus of Valsalva
Current Cardiology Reviews Saving the Ischemic Penumbra: Potential Role for Statins and Phosphodiesterase Inhibitors
Current Vascular Pharmacology Current Genomics in Cardiovascular Medicine
Current Genomics Pharmacology of Ivabradine and the Effect on Chronic Heart Failure
Current Topics in Medicinal Chemistry In Silico hERG Modeling: Challenges and Progress
Current Computer-Aided Drug Design Crucial Role of Interferon-γ and Stimulated Macrophages in Cardiovascular Disease
Current Vascular Pharmacology Long Term Complications in Pediatric Liver Transplant Recipients: What Every Pediatrician Should Know
Current Pediatric Reviews Is Combined Angiotensin-converting Enzyme Inhibition and Angiotensin Receptor Blockade Associated with Increased Risk of Cardiovascular Death in Hemodialysis Patients?
Current Hypertension Reviews Excess Cardiovascular Risk in Inflammatory Rheumatic Diseases: Pathophysiology and Targeted Therapy
Current Pharmaceutical Design MicroRNAs in the Diagnosis and Treatment of Unstable Angina
Current Topics in Medicinal Chemistry Cytokine Gene Polymorphism in Heart Transplantation: A Review
Current Genomics Chemoprevention of Colorectal Cancer: Progress or Pipedream?
Current Cancer Therapy Reviews An Exceptional Case of Atrial Fibrillation Arrhythmia Induced by Etoposide
Current Drug Safety Novel Pharmacologic Approaches to the Management of Sepsis: Targeting the Host Inflammatory Response
Recent Patents on Inflammation & Allergy Drug Discovery Preface
Current Drug Targets - Infectious Disorders Is Targeting microRNAs the Philosopher’s Stone for Vascular Disease?
Current Vascular Pharmacology Novel Therapeutic Strategies for Dementia
CNS & Neurological Disorders - Drug Targets Semicarbazide-Sensitive Amine Oxidase/Vascular Adhesion Protein 1: Recent Developments Concerning Substrates and Inhibitors of a Promising Therapeutic Target
Current Medicinal Chemistry